Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells

Recruiting now

Conditions studied: Pregnant, Healthy Females, Healthy Male Newborns

In brief

Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.

Key facts

Study ID

NCT00801372

Run by

Hadassah Medical Organization

People needed

1

Starts

2008-11-01

Expected to finish

2030-12-01

Last updated by the study team

2025-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy, older than 18

You may not qualify if…

• non healthy, younger than 18

Where it is running

• Hadassah Ein Kerem — Jerusalem, Israel, Israel (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.